Please provide your email address to receive an email when new articles are posted on . “The prednisone dosage in treatment of moderate to severe (myasthenia gravis [MG]) is commonly gradually ...

Avacopan and prednisone taper were associated with similar and substantial improvements in the control of active disease in multiple organ systems in the phase 3 ADVOCATE trial. Patients with ...

The risks of tapering steroids in a patient on a dose of 10 mg per day for 1 year should be small if the steroids are tapered gradually. At our clinic, we would initially drop to prednisone 7.5 mg per ...

Please provide your email address to receive an email when new articles are posted on . Baseline prednisone use is associated with an increased risk for poor outcomes among patients with systemic ...

A combination of tocilizumab plus prednisone-tapered therapy was superior to placebo plus steroid taper for achieving glucocorticoid-free remission in giant-cell arteritis (GCA), the phase 3 ...

Dear Dr. Roach: I am an 85-year-old woman. About seven years ago, I was diagnosed with Lyme disease and put on prednisone. I have been weaned off a few times, but I always got sick and had to go back ...

Avacopan was safe and effective among patients with respiratory tract manifestations of antineutrophil cytoplasmic antibody-associated vasculitis. Avacopan shows promising efficacy and safety among ...

I’d become an eating machine with a loathsome attitude on prednisone, so I decided to conduct my own taper of the drug. Four months after my allogeneic bone marrow transplant, I left the Stanford ...

Gradual withdrawal of glucocorticoids was successful among patients with systemic lupus erythematosus (SLE) after 2 years of clinically quiescent disease, without an increased likelihood of flares, ...

Miriam Freimer, MD, clinical professor of neurology at The Ohio State University Wexner Medical Center, reflects on how findings from the RAISE-XT trial potentially translate to real-world practice ...

Credit: Getty images. Study authors assessed whether the addition of a prednisone taper could decrease opioid use in patients undergoing tonsillectomy, tonsillectomy and adenoidectomy, or expansion ...

ENGLEWOOD CLIFFS, N.J.--(BUSINESS WIRE)--Immune Pharmaceuticals, Inc. (NASDAQ:IMNP) a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and inflammatory ...